Inventor
MILLER GUY M
US14 patents
⚠️ This page may combine multiple inventors who share the name “MILLER GUY M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EDISON PHARMACEUTICALS INC
5 patentsUS7432305B2Oct 7, 2008
Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EDISON PHARMACEUTICALS INC60 citations97
US8653144B2Feb 18, 2014
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC32 citations96
US9399612B2Jul 26, 2016
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC12 citations92
US9370496B2Jun 21, 2016
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
EDISON PHARMACEUTICALS INC20 citations92
US8969420B2Mar 3, 2015
Treatment of pervasive developmental disorders with redox-active therapeutics
EDISON PHARMACEUTICALS INC9 citations83
MILLER GUY M
5 patentsUS8314153B2Nov 20, 2012
Treatment of pervasive developmental disorders with redox-active therapeutics
MILLER GUY M51 citations96
US9278085B2Mar 8, 2016
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
MILLER GUY M19 citations91
US9447006B2Sep 20, 2016
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
MILLER GUY M7 citations83
US11021424B2Jun 1, 2021
Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
MILLER GUY M0 citations61
US10039722B2Aug 7, 2018
Treatment of oxidative stress disorders including contrast nephropathy, radiation damage and disruptions in the function of red cells
MILLER GUY M0 citations51
BIOELECTRON TECH CORP
3 patentsUS10105325B2Oct 23, 2018
Treatment of pervasive developmental disorders with redox-active therapeutics
BIOELECTRON TECH CORP4 citations83
US9932286B2Apr 3, 2018
Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
BIOELECTRON TECH CORP3 citations72
US10195161B2Feb 5, 2019
Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
BIOELECTRON TECH CORP1 citations61